ENTITY

Avrobio Inc (AVRO US)

3
Analysis
Health CareUnited States
Avrobio, Inc. operates as a bio-technology company. The Company develops step-change cell and gene therapies for the treatment of cancer and rare disease. Avrobio serves clients in the United States and Canada.
more
bullishAvrobio Inc
26 Oct 2025 07:06Primer

Primer: Avrobio Inc (AVRO US) - Oct 2025

AVROBIO, Inc. has ceased to operate as an independent entity following a reverse merger with Tectonic Therapeutic, which closed in June 2024....

Logo
αSK
495 Views
Share
bullishAvrobio Inc
02 Feb 2024 06:45Syndicated

Some updates

From what I have read from people more knowledgeable about biotechs, they have some promising treatments in development with pretty impressive...

Share
bullishI-Mab
04 Jan 2024 07:10Syndicated

Quick Ideas #6

First of all, happy new year to all my readers! May 2024 bring market beating returns for everyone. Again I managed to underperform my blog stock...

Share
No more insights
x